Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 27;140(25):8037-8047.
doi: 10.1021/jacs.8b05243. Epub 2018 Jun 19.

Redox-Neutral Photocatalytic Cyclopropanation via Radical/Polar Crossover

Affiliations

Redox-Neutral Photocatalytic Cyclopropanation via Radical/Polar Crossover

James P Phelan et al. J Am Chem Soc. .

Abstract

A benchtop stable, bifunctional reagent for the redox-neutral cyclopropanation of olefins has been developed. Triethylammonium bis(catecholato)iodomethylsilicate can be readily prepared on multigram scale. Using this reagent in combination with an organic photocatalyst and visible light, cyclopropanation of an array of olefins, including trifluoromethyl- and pinacolatoboryl-substituted alkenes, can be accomplished in a matter of hours. The reaction is highly tolerant of traditionally reactive functional groups (carboxylic acids, basic heterocycles, alkyl halides, etc.) and permits the chemoselective cyclopropanation of polyolefinated compounds. Mechanistic interrogation revealed that the reaction proceeds via a rapid anionic 3- exo- tet ring closure, a pathway consistent with experimental and computational data.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1.
Figure 1.
Cyclopropane-containing pharmacons and trifluoromethyl cyclopropanes.
Figure 2.
Figure 2.
Synthesis of trifluoromethyl-substituted cyclopropanes.
Figure 3.
Figure 3.
Convergent strategies to TFCps from commercial materials.
Figure 4.
Figure 4.
Plausible Mechanism for Cyclopropanation.
Scheme 1.
Scheme 1.
Synthesis and Optimization of the Bifunctional Silicate Reagent
Scheme 2.
Scheme 2.
Zero Precaution Reaction
Scheme 3.
Scheme 3.
Stereoconvergent Cyclopropanation
Scheme 4.
Scheme 4.
Insensitivity of Cyclopropanation to Electronicsa
Scheme 5.
Scheme 5.
Influence of Halogen Substituent on the Barriers for the SH2-type 3-exo-tet Cyclization Pathway.a
Scheme 6.
Scheme 6.
Energetics of Anionic 3-exo-tet Cyclization Versus E1cb-type Fluoride Eliminationa
Scheme 7.
Scheme 7.
Energetics of Anionic Versus Radical 3-exo-tet Cyclization in a Non-α-Trifluoromethyl Systema
Scheme 8.
Scheme 8.
Bracketing Experiment.
Scheme 9.
Scheme 9.
Energetics of Ring Opening Versus Anionic Cyclizationa

References

    1. Talele TT The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. J. Med. Chem 2016, 59, 8712–8756. - PubMed
    2. Njardson Lab. Top 200 Brand Name Drugs by Retail Sales in 2016. http://njardarson.lab.arizona.edu/sites/njardarson.lab.arizona.edu/files... (accessed Feb 23, 2018)
    3. The Drugbank. Chemical Structure Search https://www.drugbank.ca/structures/search/small_molecule_drugs/structure... (accessed Feb 23, 2018).
    1. Chen DY-K; Pouwer RH; Richard J-A Recent advances in the total synthesis of cyclopropane-containing natural products. Chem. Soc. Rev 2012, 41, 4631–4642. - PubMed
    1. Barnes-Seeman D; Jain M; Bell L; Ferreira S; Cohen S; Chen X-H; Amin J; Snodgrass B; Hatsis P Metabolically Stable tert-Butyl Replacement. ACS Med. Chem. Lett 2013, 4, 514–516. - PMC - PubMed
    2. Lazerwith SE; Lew W; Zhang J; Morganelli P; Liu Q; Canales E; Clarke MO; Doeffler E; Byun D; Mertzman M; Ye H; Chong L; Xu L; Appleby T; Chen X; Fenaux M; Hashash A; Leavitt SA; Mabery E; Matles M; Mwangi JW; Tian Y; Lee Y-J; Zhang J; Zhu C; Murry BP; Watkins WJ Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection. J. Med. Chem 2014, 57, 1893–1901. - PubMed
    3. Westphal MV; Wolfstädter BT; Plancher J-M; Gatfield J; Carreira EM Evaluation of tert-Butyl Isosteres: Case Studies of Physicochemical and Pharmacokinetic Properties, Efficacies, and Activities. Chem. Med. Chem 2015, 10, 461–469. - PubMed
    4. Bezencon Olivier; Heidmann Bibia; Siegrist R; Stamm S; Sylvia R; Pozzi D; Corminboeuf O; Roch C; Kessler M; Ertel EA; Reymond I; Pfeifer T; de Kanter R; Toeroek-Schafroth M; Moccia LG; Mawet J; Moon R; Rey M; Capeleto B; Fournier E Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies. J. Med. Chem 2017, 60, 9769–9789. - PubMed
    1. Reviews on CF3 cyclopropanes:

    2. Bos M; Poisson T; Pannecoucke X; Charette AB; Jubault P Recent Progress Toward the Synthesis of Trifluoromethyl- and Difluoromethyl-Substituted Cyclopropanes, Chem –Eur. J 2017, 23, 4950–4961; - PubMed
    3. Grygorenko OO; Artamonov OS; Komarov IV; Mykhailiuk PK Trifluoromethyl-substituted cyclopropanes Tetrahedron 2011, 67, 803
    1. Some alternate strategies to access these type of CF3 cyclopropanes: Cationic ring closure:

    2. Mercadante MA; Kelly CB; Hamlin TA; Delle Chiaie KR; Drago MD; Duffy KK; Dumas MT; Fager DC; Glod BLC; Hansen KE; Hill CR; Leising RM; Lynes CL; MacInnis AE; McGohey MR; Murray SA; Piquette MC; Roy SL; Smith RM; Sullivan KR; Truong BH; Vailonis KM; Gorbatyuk V; Leadbeater NE; Tilley LJ 1,3-γ-Silyl-elimination in electron-deficient cationic systems Chem. Sci 2014, 5, 3983–3994.;
    3. Kelly CB; Mercadante MA; Carnaghan ER; Doherty MJ; Fager DC; Hauck JJ; MacInnis AE; Tilley LJ; Leadbeater NE Synthesis of perfluoroalkyl-substituted vinylcyclopropanes by way of enhanced neighboring group participation Eur. J. Org. Chem 2015, 4071–4076.; Via Minisci-type alkylation of heteroarenes:
    4. Gianatassio R; Kawamura S; Eprile CL; Foo K; Ge J; Burns AC; Collins MR; Baran PS Simple sulfinate synthesis enables C–H trifluoromethylcyclopropanation Angew. Chem., Int. Ed 2014, 53, 9851–9855. - PMC - PubMed

Publication types